期刊文献+

聚乳酸微球表面的氨等离子体表面改性 被引量:11

Surface Modification of Poly (d,l-lactic acid) Microspheres by Ammonia Low-Temperature Plasma
下载PDF
导出
摘要 分别以聚乙烯醇和壳聚糖溶液为外水相制备了疏水性聚乳酸(PDLLA)微球,并采用氨气氛下低温等离子体技术进行修饰,以产生较高的亲水性表面。以X-光电子能谱(XPS)、接触角和薄层层析法(TLW)研究PDLLA微球表面特性及亲水性。研究结果表明,含氮基团能通过低温氨气氛等离子体处理而连接到微球表面。微球表面的亲水性与未经处理的微球相比有所提高,对于表面改性后的微球,其接触角明显降低。 The hydrophobic poly (d,l-lactic acid)(PDLLA) micropsheres were prepared in poly vinyl alcohol and chitosan solution respectively as aqueous phase,and then modified by low-temperature plasma technique.Surfaces of microspheres treated by ammonia plasma were characterized with X-ray photoelectron spectroscopy (XPS),and their wettability was studied by Contact Angle and Thin Layer Wicking measurements.It is obtained that groups contained nitrogen atoms could be introduced into the surfaces of the microspheres surfaces by low-temperature ammonia plasma.The hydrophilic character of the modified surfaces was increased in comparison with that of the parent microspheres.The contact angle for modified PDLLA microspheres were reduced apparently.
出处 《化学工业与工程》 CAS 2004年第1期17-20,32,共5页 Chemical Industry and Engineering
关键词 氨等离子体 聚乳酸 表面改性 ammonia low-temperature plasma poly(d,l-lactic acid) surface modification
  • 相关文献

参考文献9

  • 1NORRIS D A, PRUI N, LABIBK M E, et al. Determining the absolute surface hydrophobicity of microparticulates using thin layer wicking [ J ] . Journal of Controlled Release,1999,59:173 - 85.
  • 2GREF R. The controlled intravenous delivery of drugs using PEG- coated sterically stabilized nanospheres[ J]. Adv Drug Deliv Rev, 1995,16 : 215 - 33.
  • 3BAZILE D. STEALTH M E. PLA- PEG nanoparticles avoid uptake by the mononuclear phagocytes system [ J ]. J Pharm Sci, 1995,84:493 - 498.
  • 4JUNG T, KAMM W, BREITENBACH A, et al. Biodegradable nanoparticles for oral delivery of peptides : is there a role for polymers to affect mucosal uptake [ J ].European Journal of Pharmaceutics and Biopharmaceutics,'2000,50:147 - 160.
  • 5BARRATT G M. Therapeutic applications of colloidal drug carriers[J] .PSTT,2000,3(5) : 163 - 171.
  • 6SCHIPPER N G, OISSON S, HOOGSTRAATE J A, et al. Chitosans as absorption enhancers for poorly absorbable drugs 2 : mechanism of absorption enhancement [ J ] . Pharm Res, 1997,14:923 - 929.
  • 7YUAN S, SZAKALAS - GRATZ G, ZIATS N P, et al.Immobilization of high - affinity heparin oligosaccharides to radiofrequeney plasma- modified polyethylene[ J ]. J Biomed Mat Res, 1993,27:811.
  • 8BOURY F, MARCHAIS H, BENOIT J P, et ol. Surface characterization of poly (α - hydroxy acid ) microspheres prepared by a solvent evaporation/extraction process [ J ].Biomaterials, 1997,18 : 125 - 136.
  • 9HIROFUMI T, HIROMITSU Y, YOSHIAKI K. Mucoadhesive nanoparticulate system for peptide drug delivery [ J ].Advanced Drug Delivery Reviews, 2001,47 : 39 - 54.

同被引文献201

引证文献11

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部